OrganiGram (OGI)
(Real Time Quote from BATS)
$1.80 USD
-0.04 (-2.17%)
Updated Sep 20, 2024 10:54 AM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
Brokerage Reports
0 items in cart
Organigram Holdings Inc. [OGI]
Reports for Purchase
Showing records 1 - 20 ( 31 total )
Company: Organigram Holdings Inc.
Industry: Medical - Products
Company: Organigram Holdings Inc.
Industry: Medical - Products
Company: Organigram Holdings Inc.
Industry: Medical - Products
Weekly ReHash: Price Deflation a Needed Market Dynamic to Convert Illicit Mkt
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Organigram Holdings Inc.
Industry: Medical - Products
Weekly ReHash: Toronto Securities Exchange an Open Pathway for MSO Lisitngs
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Organigram Holdings Inc.
Industry: Medical - Products
Weekly ReHash: Israel - Pioneering Cannabis into a Large Market Opportunity
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Organigram Holdings Inc.
Industry: Medical - Products
Weekly ReHash: Cannabis SPACs Underperformed in 2021, Reset
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Organigram Holdings Inc.
Industry: Medical - Products
Company: Organigram Holdings Inc.
Industry: Medical - Products
Weekly ReHash: CAOA Feedback, Fall Potential Legislation Passage In Budget Bill
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Organigram Holdings Inc.
Industry: Medical - Products
Weekly ReHash: Ranking 2Q Earnings Reports, Well Capitalized MSOs
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Organigram Holdings Inc.
Industry: Medical - Products
A Day of Progress for Cannabis Legislative Reform
Provider: Roth Capital Partners, Inc.
Analyst: Research Department